An Integrative Literature Review of Heart Rate Variability Measures to Determine Autonomic Nervous System Responsiveness Using Pharmacological Manipulation.
Katherine A Maki, Madison P Goodyke, Kendra Rasmussen and 1 others
PMID 37249528WHAT IT FOUND
HRV changes after drugs that alter autonomic nerves were inconsistent for sympathetic blockade, but parasympathetic blockade lowered absolute power, entropy, and Poincare measures.
Short-term HRV is not yet a consistent cardiovascular risk predictor.
Key findings
01The review synthesized 19 original studies, including 11 human and 8 rodent HRV studies.
02In humans, sympathetic blockade increased mean RR interval but did not change SDNN, VLF power, LF power, HF power, or normalized LF.
03In humans, parasympathetic blockade decreased absolute VLF, LF, and HF power; after atropine or methylatropine, approximate entropy, sample entropy, SD1, and SD2 also decreased.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The included studies used different drugs, doses, routes, recording lengths, sampling rates, and HRV metrics, so results are hard to compare. Human studies often had small, mostly male samples, and females were underrepresented, so sex differences were mostly not tested. The review included studies regardless of quality score because the appraisal tool has no cut point for acceptable quality. Short-term HRV measures have not yet been shown to be consistently predictive of cardiovascular outcomes compared with long-term measures. Only English-language articles were searched, which may limit generalizability. The review did not pool patient outcomes, so it cannot show that HRV changes or autonomic drugs improve patient care.
Declared interests
The article is tagged as NIH intramural research support, and the authors declared no potential conflicts of interest.
The easy way to misread this
Do not read these HRV changes as proof that any treatment improves cardiovascular outcomes. The review synthesized pharmacologic manipulation studies, not patient outcomes, and it says short-term HRV measures have not yet been shown to be consistently predictive of cardiovascular outcomes.